The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure

American Heart Journal

Volumn 151, Issue 1, 2006, Pages 62-68

  Gong, Kaizheng ^a   Zhang, Zhengang ^b   Sun, Xiaonin ^a   Zhang, Xin ^a   Li, Aihua ^a   Yan, Junfeng ^a   Luo, Qiuping ^a   Gao, Yang ^a   Feng, Yiliang ^a  

^a Medical College of Southeast University   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GOUT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WALKING;

ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION MEDIATORS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 29144481887     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.040     Document Type: Article

References (26)

1. B. Levine, J. Kalman, and L. Mayer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
2. S.D. Anker Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
3. B. Bozkurt, G. Torre-Amione, and M.S. Warren Results of targeted anti-tumor necrosis factor therapy with Etanercept (ENBREL) in patients with advanced heart failure Circulation 103 2001 1044 1047
4. E.S. Chung, M. Packer, and K.H. Lo Randomized, double-blind, placebo-controlled, pilot trial of Infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure. Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial Circulation 107 2003 3133 3140
5. D.E. Furst The rational use of methotrexate in rheumatoid arthritis and other rheumatic disease Br J Rheumatol 36 1997 1196 1204
6. K.K. Ho, J.L. Pinsky, and W.B. Kannel The epidemiology of heart failure: the Framingham study J Am Coll Cardiol 22 1993 6A 13A
7. D.J. Sahn, A. DeMaria, and J. Kisslo The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
8. G.H. Guyatt, M.J. Sullivan, and P.J. Thompson The six-minute walk: a new measure of exercise capacity in patients with chronic heart failure Can Med Assoc J 132 1985 919 923
9. C.L.K. Lam, B. Gandek, and X.S. Ren Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 health survey J Clin Epidemiol 51 1998 1139 1147
10. A. Deswal, N.J. Petersen, and A.M. Feldman Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone Trial (VEST) Circulation 103 2001 2055 2059
11. J.K. Damas, H.G. Eiken, and E. Oie Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure Cardiovasc Res 47 2000 778 787
12. T. Kubota, M. Miyagishima, and R.J. Alvarez Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure J Heart Lung Transplant 19 2000 819 824
13. M.S. Finkel, C.V. Oddis, and T.D. Jacob Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
14. T. Yokoyama, M. Nakano, and J.L. Bednarczyk Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes Circulation 95 1997 1247 1252
15. D.J. Ing, J. Zang, and V.J. Dzau Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak and Bcl-x Circ Res 84 1999 21 33
16. D.A. Siwik, D.L. Chang, and W.S. Colucci Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro Circ Res 86 2000 1259 1265
17. F. Wolfe, and K. Michaud Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy Am J Med 116 2004 305 311
18. H.K. Choi, M.A. Hernan, and J.D. Seeger Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
19. H. Takehana, T. Inomata, and H. Niwano Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis Circ J 66 2002 499 504
20. K. Sliwa, A. Woodiwiss, and V.N. Kone Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline Circulation 109 2004 750 755
21. L. Gullestad, H. Aass, and J.G. Fjeld Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure Circulation 103 2001 220 225
22. N. Hornung, K. Stengaard-Pedersen, and E. Ehrnrooth The effects of low-dose methotrexate on thymidylate synthase activity in human peripheral blood mononuclear cells Clin Exp Rheumatol 18 2000 691 698
23. L. Morabito, M.C. Montesinos, and D.M. Schreibman Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides J Clin Invest 101 1998 295 300
24. M. Cutolo, A. Sulli, and C. Pizzorni Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis Ann Rheum Dis 60 2001 729 735
25. S. Fichtlscherer, L. Rossig, and S. Breuer Tumor necrosis factor antagonism with Etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure Circulation 104 2001 3023 3025
26. N.G. Papadopoulos, Y. Alamanos, and I.A. Papadopoulos Disease modifying antirheumatic drugs in early rheumatoid arthritis: a long-term observational study J Rheumatol 29 2002 261 266